Cell And Gene Therapy Outcomes-Based Contracts In Medicaid Need ‘National’ Support,' HHS Says

The demonstration project planned by the US Centers for Medicare and Medicaid Services is in keeping with past agency efforts to promote value-based contracts for cell and gene therapy.

Sickle Cell and Cancer Treatments Could Be Subject To the CMMI Demonstration. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies